Skip to content

Can a 5-Session Cognitive Behaviour Therapy Intervention Improve Emotional Distress and Quality of Life for Allogeneic Hematopoietic Stem Cell Transplant Survivors?

Can a 5-Session Cognitive Behaviour Therapy Intervention Improve Emotional Distress and Quality of Life for Allogeneic Hematopoietic Stem Cell Transplant Survivors?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001663246
Enrollment
10
Registered
2018-10-09
Start date
2020-01-07
Completion date
2020-10-20
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to see if a 5 session psychological therapy program delivered after bone marrow transplantation can have a positive impact on quality of life and psychological distress in these patients. Who is it for? You may be eligible for this study if you are aged 18 or older and have received a bone marrow transplant in the last 3 to 12 months. Study details All participants in this study will receive 5 individual sessions of face-to-face cognitive behavioural therapy targeting mental adjustment and coping strategies. Participants will also need to do approximately 10 minutes of ‘homework’ every day following each of the first 4 sessions. As part of the study, participants will complete questionnaires about their quality of life, psychological distress, mental adjustment, coping and self-efficacy before and after the 5 session intervention. Participants will also be asked to complete questionnaires about their psychological distress and homework completion at each session. It is hoped this research will provide evidence this program improves mental health outcomes in this patient population.

Interventions

Cognitive Behavioural Therapy (CBT) for Allogeneic Hematopoetic Stem-Cell Transplantation (HSCT) Survivors is an intervention designed to provide brief and focused psychotherapeutic CBT treatment for psychological distress and HRQoL through specifically targeting recipients’ mental adjustment and coping responses. The intervention will consists of face-to-face or telehealth delivered individual counselling sessions of 1 hour a week for 5 sessions with a psychology trainee within a Doctorate of C

Cognitive Behavioural Therapy (CBT) for Allogeneic Hematopoetic Stem-Cell Transplantation (HSCT) Survivors is an intervention designed to provide brief and focused psychotherapeutic CBT treatment for psychological distress and HRQoL through specifically targeting recipients’ mental adjustment and coping responses. The intervention will consists of face-to-face or telehealth delivered individual counselling sessions of 1 hour a week for 5 sessions with a psychology trainee within a Doctorate of Clinical Psychology program at Monash University. Content of these sessions is broadly focused on the following, Defining Values and Goals Setting, Understanding and Managing Your Emotions, Enhancing Personal Control and Mastery, Developing More Constructive Thinking, Changing Your Thinking. Homework is scheduled following each session of approximately 10 minutes a day. Homework following each session broadly consists of the following, Defining Values & Goals, Practising Deep Breathing, Engaging in Pleasurable Activities, and completing Dysfunctional Though Records. The intervention will be delivered at both The Alfred Hospital and The Peter MacCallum Cancer Centre.

Sponsors

Peter Norton
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants will be allogeneic HSCT recipients who are English speaking, over 18 years of age, and who are 3-12 months post-transplantation.

Exclusion criteria

Experiencing a delirium, currently receiving psychotherapeutic treatment or unable to individually provide full informed consent (due to intellectual disability, acute medical illness etc).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026